GlassScriptPhysician profile
Megan S Scheller
NPI 1346916103
$1,367.86
in general payments reported to CMS, 2019-2025
23 companies · $28.89 in 2025
The $28.89 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $904 · 2023: $151 · 2024: $77.60 · 2025: $28.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $185.15 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $125.34 | 2021-2022 | |
| 180 Medical, INC. | $120.39 | 2021-2022 | |
| Medtronic, INC. | $117.64 | 2022-2023 | Interstim |
| Abbvie INC. | $98.29 | 2021-2023 | |
| Myovant Sciences INC. | $96.23 | 2021-2022 | |
| Janssen Biotech, INC. | $81.69 | 2022 | |
| Novartis Pharmaceuticals Corporation | $70.07 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $61.33 | 2022 | |
| Endo Pharmaceuticals INC. | $55.61 | 2021-2022 | |
| Astellas Pharma US INC | $55.05 | 2022 | |
| Sun Pharmaceutical Industries INC. | $46.33 | 2022 | |
| Bioventus LLC | $40.43 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Accord Healthcare, INC. | $36.84 | 2022 | |
| Merck Sharp & Dohme LLC | $36.30 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $27.17 | 2022-2023 | Seglentis |
| Progenics Pharmaceuticals, INC. | $19.82 | 2022 | |
| Djo, LLC | $19.12 | 2024 | Cmf |
| Axonics, INC. | $16.33 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.70 | 2023 | Nuzyra |
| Allergan, INC. | $15.54 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.35 | 2025 | |
| Teleflex LLC | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Scheller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.